PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results